Fdg-pet/ct in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial

HIGHLIGHTS

  • who: Elizabeth J. de Koster from the Department of Biomedical Sciences and Humanitas Clinical Humanitas University, Milan, Italy have published the Article: FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial, in the Journal: (JOURNAL)

SUMMARY

    This study adhered to this local histopathological diagnosis as a reference standard, as this diagnosis likely best reflects the patient`s illness perception and estimated costs. Year costs and utilities Real-world volumes of thyroid nodule-related health care consumption for 1 year, counted from the date of the ­[18F] FDG . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?